Showing 1 - 10 of 261
Persistent link: https://www.econbiz.de/10001806697
Health care expenditures have been increasing sharply in the last ten years, with spending on mental health disorders being particularly prominent. Over the same time period, a number of new antipsychotic medications have been added to the armamentarium for treatment of persons diagnosed with...
Persistent link: https://www.econbiz.de/10013227064
Persistent link: https://www.econbiz.de/10003097357
Health accounts document changes over time in the level and composition of health spending. There has been a continued evolution in the ability to track such outlays. Less rapid has been the ability to interpret changes in spending. In this paper we apply quality adjusted price indexes for...
Persistent link: https://www.econbiz.de/10012467121
Health care expenditures have been increasing sharply in the last ten years, with spending on mental health disorders being particularly prominent. Over the same time period, a number of new antipsychotic medications have been added to the armamentarium for treatment of persons diagnosed with...
Persistent link: https://www.econbiz.de/10012468676
Persistent link: https://www.econbiz.de/10010289764
Persistent link: https://www.econbiz.de/10003326251
We examine the price of treating episodes of acute phase major depression over the 1991-1996 time period. We combine data from a large retrospective medical claims data base (MarketScanTM, from the MedStat Group) with clinical literature and expert clinical opinion elicited from a two-state...
Persistent link: https://www.econbiz.de/10012470934
This paper investigates the impact of depression on labor force participation among older workers. Empirically, we use two analytic strategies and rely on a sample drawn from the Health and Retirement Survey. Depression directly and indirectly increases individuals%u2019 probability of retiring...
Persistent link: https://www.econbiz.de/10012780122
Generic drug prices have been the focus of much attention in recent years, with Congressional committees, executive agencies and private organizations all conducting investigations into the pricing patterns for generic drugs. Price spikes for selected old, off-patent drugs have also been widely...
Persistent link: https://www.econbiz.de/10012865747